| Title | Onkológia
|
|---|
| Year, No. | Roč. 6, č. 1, rok 2011
|
|---|
| ISSN | 1336-8176
|
|---|
| Issue data | Bratislava : SOLEN, 2011
|
|---|
| Phys.des. | s. 4-62
|
|---|
| Collective Record/Entry | Onkológia
|
|---|
| Onkológia
|
|---|
| Language | Slovak
|
|---|
| Country | Slovakia
|
|---|
| Copy count | 2, currently available 0, at library only 2
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Pokroky v klinickej onkológii 2010 = Clinical cancer advances 2010 : výročná správa Americkej spoločnosti klinickej onkológie o pokrokoch proti nádorovým ochoreniam / / Peter Beržinec
|
|---|
| Identification of carbonic anhydrase I immunodominant epitopes recognized by specific autoantibodies which indicate an improved prognosis.. / Skultety L. ... [et al.]
|
|---|
| Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III.. / van Oers M. H. ... [et al.]
|
|---|
| BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/res.. / van Oers M. H. ... [et al.]
|
|---|
| Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like.. / R. Godal ... [et al.]
|
|---|
| Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic.. / M. E. Gore ... [et al.]
|
|---|
| Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial / / C. N. Sternberg ... [et al.]
|
|---|
| Therapy of small cell lung cancer with emphasis on oral topotecan / / R. Pirker ... [et al.]
|
|---|
| Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial / / J. Ocvirk ... [et al.]
|
|---|
| Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer / / De Giorgi U. ... [et al.]
|
|---|
| Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or.. / A. Tomova ... [et al.]
|
|---|
| 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer / / De Giorgi U. ... [et al.]
|
|---|
| MDR1 (C3435T) polymoprphism: relation to the risk of breast cancer and therapeutic outcome / / M. Cizmarikova ... [et al.]
|
|---|
| Molecular mechanisms of metastasis in breast cancer-clinical applications / / M. Mego, S. A. Mani, M. Cristofanil..
|
|---|
| Správa z konferencie Aktuálne problémy v manažmente gastrointestinálnych malignít / / Tomáš Šálek, Peter Pichňa
|
|---|
| 12. Stredoeurópska konferencia o karcinóme pľúc / / Peter Beržinec
|
|---|
| Pacientka s metastatickým adenokarcinómom hrubého čreva, liečená chemoterapiou v kombinácii s bevacizumabom = A patient with metastatic colorectal adenocarcinoma treated.. / Patrik Palacka ... [et al.]
|
|---|
| Protinádorová liečba u pacientov s hepatálnou insuficienciou = Anti-tumor therapy in patients with liver insufficiency / / Michal Mego, Ján Rajec
|
|---|
| Kapecitabín a jeho význam v liečbe pokročilého HER2-pozitívneho karcinómu prsíka = Capecitabine and its role in the treatment of advanced HER2 positive breast cancer / / Radovan Barilla, Igor Andrašina
|
|---|
| Biologická liečba a chronická myelocytová leukémia = Biological treatment and chronic myeloid leukemia / / Elena Tóthová
|
|---|
| Biologická liečba lymfómov = Lymphoma biologic therapy / / Andrej Vranovský
|
|---|
| Gastrointestinálne stromálne tumory = Gastrointestinal stromal tumors / / Jozef Šufliarsky
|
|---|
| Biologická a cielená liečba urogenitálnych malignít = Biologic and targeted therapy for urogenital malignities / / Mária Rečková
|
|---|
| Cielená biologická liečba pri karcinóme pľúc - aktuálny stav a perspektívy = Targeted biological therapy for lung cancer - current status and perspectives / / Peter Beržinec
|
|---|
| Úloha patológa v biologickej liečbe zhubných nádorových ochorení = The pathologist's contribution for a targeted biological therapy of neoplastic disorders / / Lukáš Plank
|
|---|
